Significant Ownership of Joseph K. Belanoff

Location
Menlo Park, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Joseph K. Belanoff.

Follow Filing Activity

Follow Joseph K. Belanoff and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of Joseph K. Belanoff

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CORT Corcept Therapeutics Incorporated Common Stock 6.3% $499,599,592 6,822,335 Joseph K. Belanoff 31 Dec 2024

Schedules 13D/G Reported by Joseph K. Belanoff:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.